Drug – bio-affecting and body treating compositions – Nonspecific immunoeffector – per se ; or nonspecific... – Bacterium or component thereof or substance produced by said...
Patent
1994-12-09
1998-06-02
Budens, Robert D.
Drug, bio-affecting and body treating compositions
Nonspecific immunoeffector, per se ; or nonspecific...
Bacterium or component thereof or substance produced by said...
4242481, 4242791, A61K 4500, A61K 4505
Patent
active
057595542
ABSTRACT:
The present invention relates to an immunotherapeutic agent that is effective in treating a variety of diseases in animals and humans. More particularly, the present invention is a preparation of a modified mycobacterial cell wall extract that does not contain oil, that is capable of stimulating the immune system of an animal or human in such a way as to cause the body to neutralize, abort or eliminate infections, tumors and other disorders.
REFERENCES:
patent: 3172815 (1965-03-01), Fox et al.
patent: 3331741 (1967-07-01), Anschel et al.
patent: 3529057 (1970-09-01), Tsuchiya
patent: 4010257 (1977-03-01), Adlam et al.
patent: 4013788 (1977-03-01), Jolles et al.
patent: 4036953 (1977-07-01), Adam et al.
patent: 4069314 (1978-01-01), Adlam et al.
patent: 4110434 (1978-08-01), Jolles et al.
patent: 4340586 (1982-07-01), Bekierkunst
patent: 4503048 (1985-03-01), Cantrell
patent: 4504473 (1985-03-01), Cantrell
patent: 4505903 (1985-03-01), Cantrell
patent: 4663311 (1987-05-01), Tenu et al.
patent: 4744984 (1988-05-01), Ragland et al.
McLaughlin, C.A., et al., "Regression of Tumors in Guinea Pigs after Treatment with Synthetic Muramyl Dipeptides and Trehalose Dimycolate", Science, vol. 208, pp. 415-416 (Apr. 25, 1980).
Charley, B., et al., "In vitro effects of lipopolysaccharides and mycrobacterial cell wall components on swine alveolar macrophages," Research in Veterinary Science, vol. 34, pp. 212-217 (1983).
Lederer, E., "Synthetic Immunostimulants Derived from the Bacterial Cell Wall," Journal of Medicinal Chemistry, vol. 23, No. 8, pp. 819-821 (Aug. 1980).
Chess, L., M.D., et al., "Immunologic Effects of BCG in Patients with Malignant Melanoma: Specific Evidence for Stimulation of the Secondary Immune Response," Journal of the National Cancer Institute, vol. 51, No. 1, pp. 57-65 (Jul. 1973).
Bast, R.C., Jr., M.D., et al., "BCG and Cancer," The New England Journal of Medicine, vol. 29, No. 25, pp. 1413-1420 (Jun. 20, 1974).
Chedid, L., et al., "Enhancement of nonspecific immunity to Klebsiella pneumoniae infection by a synthetic immunoadjuvant (N-acetylmuramyl-L-alanyl-D-isoglutamine) and several analogs," Proc. Natl. Acad. Sci., vol. 74, pp. 2089-2093 (1977).
Lopez-Berestein, G., et al., "The Activation of Human Monocytes by Liposome-encapsulated Muramyl Dipeptide Analogues," The Journal of Immunology, vol. 130, No. 4, pp. 1500-1502 (Apr. 1983).
Chedid, L., et al., "Protective Effect of Delipidated Mycobacterial Cells and Purified Cell Walls against Ehrlich Carcinoma and a Syngeneic Lymphoid Leukemia in Mice," Cancer Research, vol. 33, pp. 2187-2195 (Sep. 1973).
Meyer, T.J., et al., "Biologically Active Components from Mycrobacterial Cell Walls. II. Suppression and Regression of Strain-2 Guinea Pig Hepatoma," Journal of the National Cancer Institute, vol. 52, No. 1, pp. 103-111 (Jan. 1974).
Mathe, G., et al., "An Experimental Screening for `Systemic Adjuvants of Immunity` Applicable in Cancer Immunotherapy," Cancer Research, vol. 33, pp. 1987-1997 (Sep. 1973).
Green, H.H., "Weybridge P.P.D. Tuberculins," The Veterinary Journal (British Veterinary Journal), vol. 102, pp. 267-278 (1946).
Edelman, "Vaccine Adjuvants," Reviews of Infectious Diseases, vol. 2, No. 3, pp. 370-383 (1980).
Taniyama, et al., "Adjuvant Activity of Mycobacterial Fractions," Japan, J. Microbiol., vol. 18, No. 6, pp. 415-426 (1974).
Bernstein, et al., "Enhancement of the immune response elicited with foot-and-mouth disease virus vaccines by an extract by the Mycobacterium sp. wall," Vaccine, vol. 9, pp. 883-888 (1991).
Azuma et al., Japan J. Micobiol., vol. 15, No. 2, pp. 193-197 (1971).
Ko et al. Medical Micro & Immunol. 170(1):1-9, 1981 Abstract only.
Azuma et al., Jap. J. Microbiol, 15(2):193-197, 1971.
Edelmin et al, Rev. Infect. Dis., 2(3):370-83, 1980.
Taniyama et al., Jpn. J. Microbiol., 18(6):415-26, 1974.
Berinstein et al., Vaccine, 9:883-888, 1991.
Chedid et al, Cancer Research 33:2187-2195, 1973.
Alkemade Stanley J.
Buckley Thomas C.
McRae Graeme
Budens Robert D.
Vetrepharm, Inc.
LandOfFree
Immunostimulatory bacterial cell wall traction does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Immunostimulatory bacterial cell wall traction, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Immunostimulatory bacterial cell wall traction will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1456695